Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet De-escalation”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Post-approval studies (Phase 4)Looking for participantsNCT05681702
What this trial is testing

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease
University of Florida 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT06763744
What this trial is testing

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)High Bleeding Risk
Samsung Medical Center 3,000
Post-approval studies (Phase 4)Study completedNCT03465644
What this trial is testing

TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

Who this might be right for
Coronary Stenoses
Duk-Woo Park, MD 2,018
Very early researchNot Yet RecruitingNCT06339021
What this trial is testing

OCT or Angiography Guided De-escalation of DAPT

Who this might be right for
Optical Coherence TomographyDual Antiplatelet TherapyAntiplatelet De-escalation+2 more
Shenyang Northern Hospital 80
Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Not applicableLooking for participantsNCT06216821
What this trial is testing

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time

Who this might be right for
Acute Coronary Syndrome
Shenyang Northern Hospital 3,490
Large-scale testing (Phase 3)Looking for participantsNCT06653348
What this trial is testing

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 100
Post-approval studies (Phase 4)Looking for participantsNCT06588595
What this trial is testing

The Switching Antiplatelet-9 (SWAP-9) Study

Who this might be right for
Coronary Arterial Disease (CAD)
University of Florida 90
Large-scale testing (Phase 3)Looking for participantsNCT05577988
What this trial is testing

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Who this might be right for
MYOCARDIAL INFARCTION
Assistance Publique - Hôpitaux de Paris 2,468
Not applicableNot Yet RecruitingNCT07374718
What this trial is testing

Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk(HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 468
Not applicableUnknownNCT04848766
What this trial is testing

IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS

Who this might be right for
Acute Coronary SyndromeCoronary Artery Disease
Seoul National University Hospital 9,000
Post-approval studies (Phase 4)UnknownNCT04090281
What this trial is testing

Implementing Precision Medicine Approaches to Guide Anti-platelet Selection

Who this might be right for
Acute Coronary Syndrome (ACS)STEMI - ST Elevation Myocardial Infarction (MI)NSTEMI - Non-ST Segment Elevation MI+1 more
University of Southern California 200
Large-scale testing (Phase 3)UnknownNCT04718025
What this trial is testing

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

Who this might be right for
STEMINSTEMIUnstable Angina
Collegium Medicum w Bydgoszczy 4,500
Post-approval studies (Phase 4)Looking for participantsNCT06821191
What this trial is testing

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Who this might be right for
Coronary Artery Disease
University of Florida 78
Post-approval studies (Phase 4)Study completedNCT05380063
What this trial is testing

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

Who this might be right for
Coronary Artery DiseaseCoronary Artery Bypass GraftingDual Antiplatelet Therapy+4 more
China National Center for Cardiovascular Diseases 2,300